We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+6.39%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$9.65B
AUM Growth
+$414M
(+4.5%)
Cap. Flow
+$77.2M
Cap. Flow
% of AUM
0.8%
Top 10 Holdings %
Top 10 Hldgs %
20.18%
Holding
1,150
New
121
Increased
363
Reduced
495
Closed
137
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$53.4M |
| 2 |
Occidental Petroleum
OXY
|
+$38M |
| 3 |
Capital One
COF
|
+$36.7M |
| 4 |
Elevance Health
ELV
|
+$27.1M |
| 5 |
Kroger
KR
|
+$20.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Align Technology
ALGN
|
+$43.2M |
| 2 |
Microsoft
MSFT
|
+$36.6M |
| 3 |
Qualcomm
QCOM
|
+$34.8M |
| 4 |
Mastercard
MA
|
+$33.6M |
| 5 |
Merck
MRK
|
+$33.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.04% |
| 2 | Healthcare | 14.84% |
| 3 | Consumer Discretionary | 14.57% |
| 4 | Financials | 13.21% |
| 5 | Industrials | 8.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
876
Adicet Bio
ACET
$77.6M
| $327K | ﹤0.01% |
+1,719
| New | +$435K |
|
|
INFI
877
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $325K | ﹤0.01% |
277,550
| – | – |
|
|
ATXS
878
DELISTED
Astria Therapeutics
ATXS
| $323K | ﹤0.01% |
+8,695
| New | +$345K |
|
|
HTBK
879
DELISTED
Heritage Commerce
HTBK
| $317K | ﹤0.01% |
47,595
-212,999
| -82% | -$1.47M |
|
|
GRTX
880
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
| $317K | ﹤0.01% |
35,028
-1,133
| -3% | -$8.97K |
|
881
Zebra Technologies
ZBRA
$13.5B
| $316K | ﹤0.01% |
1,250
| – | – |
|
|
HIL
882
DELISTED
Hill International, Inc. Common Stock
HIL
| $312K | ﹤0.01% |
236,534
+27,200
| +13% | +$39.3K |
|
883
First Commonwealth Financial
FCF
$2.2B
| $311K | ﹤0.01% |
40,226
-17,814
| -31% | -$142K |
|
884
Valhi
VHI
$389M
| $311K | ﹤0.01% |
23,595
+1,500
| +7% | +$18K |
|
885
Nexstar Media Group
NXST
$6.01B
| $310K | ﹤0.01% |
+3,449
| New | +$311K |
|
886
Bright Horizons
BFAM
$4.35B
| $309K | ﹤0.01% |
2,030
-1,424
| -41% | -$179K |
|
|
MSGN
887
DELISTED
MSG Networks Inc.
MSGN
| $303K | ﹤0.01% |
31,642
+3,415
| +12% | +$34.4K |
|
888
Home Bancorp
HBCP
$558M
| $296K | ﹤0.01% |
12,252
-151
| -1% | -$3.74K |
|
|
QVCGA
889
DELISTED
QVC Group Inc Series A
QVCGA
| $296K | ﹤0.01% |
+823
| New | +$389K |
|
890
Orion Group Holdings
ORN
$368M
| $295K | ﹤0.01% |
107,168
+51,533
| +93% | +$147K |
|
891
SL Green Realty
SLG
$3.83B
| $295K | ﹤0.01% |
6,570
-53,147
| -89% | -$2.46M |
|
|
RPT
892
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $295K | ﹤0.01% |
54,151
-1,362
| -2% | -$8.36K |
|
|
SYNC
893
DELISTED
Synacor, Inc.
SYNC
| $295K | ﹤0.01% |
195,537
| – | – |
|
894
Cisco
CSCO
$443B
| $294K | ﹤0.01% |
+7,462
| New | +$325K |
|
895
Axogen
AXGN
$2.2B
| $292K | ﹤0.01% |
25,141
-32,815
| -57% | -$381K |
|
896
Green Brick Partners
GRBK
$3.09B
| $292K | ﹤0.01% |
18,132
+3,366
| +23% | +$49.6K |
|
897
Walmart Inc
WMT
$909B
| $292K | ﹤0.01% |
6,270
-216
| -3% | -$9.6K |
|
|
CWBC
898
Community West Bancshares
CWBC
$685M
| $289K | ﹤0.01% |
23,388
-2,269
| -9% | -$29.5K |
|
|
CMBM
899
DELISTED
Cambium Networks
CMBM
| $287K | ﹤0.01% |
16,988
-18,580
| -52% | -$244K |
|
900
US Bancorp
USB
$97.9B
| $284K | ﹤0.01% |
7,927
-3,070
| -28% | -$112K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2020 Portfolio in Review
As of Q3 2020, Jacobs Levy Equity Management held 1,150 positions worth $9.65B, up 4.5% from $9.23B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Jacobs Levy Equity Management's Q3 2020 filing shows 121 new, 363 increased, 495 reduced and 137 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 191,373 shares worth $14.6M. The largest sale was Align Technology, an estimated $43.2M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q3 2020 buy was BioMarin Pharmaceuticals: 191,373 shares worth $14.6M.
- Jacobs Levy Equity Management added most to Lowe's Companies in Q3 2020, an estimated $53.4M increase.
- Jacobs Levy Equity Management's biggest Q3 2020 reduction was Align Technology, cutting an estimated $43.2M.
- Jacobs Levy Equity Management fully exited Cloudera, Inc. in Q3 2020, selling an estimated $17.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 20% of its $9.65B portfolio in Q3 2020.
- Jacobs Levy Equity Management opened 121 new positions and closed 137 in Q3 2020.
- Jacobs Levy Equity Management's portfolio value rose 4.5% quarter-over-quarter to $9.65B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2020, filed 16 Nov 2020.